山水水泥(00691.HK):樞密院裁定同意天瑞的上訴 公司將會針對令狀及天瑞的主張進行積極抗辯
格隆匯11月15日丨山水水泥(00691.HK)公佈,之前披露,開曼羣島上訴法院基於天瑞的令狀存在瑕疵而裁定撤銷令狀,天瑞於2022年10月11日向樞密院提出上訴。
樞密院於2024年11月14日頒佈其判決,並裁定同意天瑞的上訴。該判決的結果是將允許天瑞以股東名義向公司直接提起主張(而非必須通過衍生訴訟提起主張)。樞密院並未就天瑞主張的實質事實理據作出任何認定,該等事宜乃待審理。
公司認為令狀所尋求的判令及╱或宣吿並無合理依據,並將會針對令狀及天瑞的主張進行積極抗辯。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.